Login / Signup

An Investigation into Cell-Free DNA in Different Common Cancers.

Samira NafarKamran HosseiniNegin ShokrgozarAmir Yousef FarahmandiVahab Alamdari-PalangiAli Saber SichaniJafar Fallahi
Published in: Molecular biotechnology (2023)
Diagnosis is the most important step in different diseases, especially in cancers and blood malignancies. There are different methods in order to better diagnose of cancer, but many of them are invasive and also, some of them are not useful for immediate diagnosis. Cell-free DNA (cfDNA) or liquid biopsy easily accessible in peripheral blood is one of the non-invasive prognostic biomarkers in various areas of cancer management. In fact, amounts of cfDNA in serum or plasma can be used for diagnosis. In this review, we have considered some cancers such as hepatocellular carcinoma, lung cancer, breast cancer, and hematologic malignancies to compare the various methods of cfDNA diagnosis.
Keyphrases
  • peripheral blood
  • childhood cancer
  • squamous cell